Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers
This grant funds clinical centers to test and optimize anti-obesity medication strategies for children and teens, focusing on health, development, and minimizing risks through collaborative research.
Funder: National Institutes of Health
Due Dates: December 1, 2026 (Estimated, forecasted)
Funding Amounts: Expected 3 awards; award size and total program funding not yet specified; cooperative agreement
Summary: Supports clinical centers to test and optimize anti-obesity medication strategies for children and adolescents, focusing on maximizing benefits and minimizing risks.
Key Information: This is a forecasted opportunity; dates and details may change—check the program page for updates.
Description
This funding opportunity invites clinical centers to join a multi-site consortium focused on evaluating and optimizing treatment strategies using anti-obesity medications (AOMs) for youth with obesity. The goal is to develop and test intervention strategies that promote healthy growth, nutritional status, mental health, and quality of life, while minimizing risks associated with AOM use. The consortium will address key questions such as the optimal timing of AOM initiation, dosing, duration, and the integration of lifestyle therapies. Investigators will also assess predictors of response and nonresponse to different treatment strategies. Participating centers will collaborate on protocol development, use of standardized measures and data collection, and joint data analysis and dissemination.
